
UK Puberty Blocker Trial Paused Amid Regulator Concerns
A clinical trial in the UK for puberty blockers has been paused after the medicines regulator raised concerns, particularly regarding the minimum age for participants.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)Sources
Puberty blockers trial paused over concerns from medicines watchdog
The medicines regulator is suggesting the minimum age limit for trial should be raised to 14.
Read full article →UK clinical trial into puberty blockers paused after medicines regulator raises concerns
Study set to delay recruitment after warning participants should be a minimum of 14 years old A clinical trial into puberty blockers for children has been paused after the medicines regulator warned it should have a minimum age limit of 14 because of the “unquantified risk” of “long-term biological harms”. Discussions between the Medicines and Healthcare products Regulatory Agency (MHRA) and the trial sponsor, King’s College London, will begin next week to discuss the wellbeing concerns, the Department of Health and Social Care (DHSC) said on Friday evening. Continue reading...
By Nadeem Badshah
Read full article →Puberty blocker trial paused over ‘new concerns’ about fertility - The Times
Puberty blocker trial paused over ‘new concerns’ about fertility The Times
Read full article →


